Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Lioux G., Temiño S., Torres M.Cardiovascular Developmental Biology and Repair Department, CNIC, Melchor Fernández Almagro, 3 (28029) Madrid, Spain.
Congenital heart defects are the most common birth defects, it is thus of importance to understand the lineage tree of heart development. So far, four main populations of heart progenitor cells have been identified in the early embryo: the first and second heart field (SHF), the proepicardium, and the neural crest cell population.
However it is not known how plastic are these progenitors in terms of fate and to which extent different lineages cross contribute to identical cell types.
I) We aim at deciphering the lineage tree of heart progenitors in Mouse using retrospective clonal analysis based on the random labeling of heart precursors. Cell labeling is performed with a ubiquitous Tamoxifen-inducible Cre recombinase triggering the expression of a LacZ and EYFP reporter. By labeling heart precursors around Embryonic day 9 (E9), we provided evidence of a common progenitor for Pericardium, epicardium, smooth muscle (SM) and endothelial cells (ECs) of the Outflow Tract OFT.
II) Using subsequent lineage tracing with SHF cre driving lines we showed that this common progenitor belongs to the SHF lineage. The following question we addressed was whether those OFT clones derive all together from the SHF or if it is a two-step process: SHF progenitors could give rise to OFT epicardium which ultimately contribute to OFT SMs and ECs.
III) Interestingly using lineage tracing of OFT epicardial-like cells we showed that, those cells remain multipotent as they substantially contribute to OFT smooth muscle and endothelium. We will now study how such cells are affected in mutants presenting a truncated OFT to further our knowledge on the cellular basis of such defects.